(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-07 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 451879
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Wed Aug 2024 | 7.83 | 7.91 | 8.38 | 7.79 | 8.639 times |
| 06 Tue Aug 2024 | 7.83 | 8.65 | 9.18 | 7.69 | 4.359 times |
| 05 Mon Aug 2024 | 9.59 | 9.24 | 9.67 | 9.24 | 0.803 times |
| 02 Fri Aug 2024 | 9.64 | 9.60 | 9.88 | 9.58 | 0.623 times |
| 01 Thu Aug 2024 | 10.03 | 10.16 | 10.22 | 9.82 | 0.526 times |
| 31 Wed Jul 2024 | 10.11 | 10.16 | 10.35 | 9.88 | 1.315 times |
| 30 Tue Jul 2024 | 10.06 | 10.18 | 10.19 | 9.93 | 0.426 times |
| 29 Mon Jul 2024 | 10.11 | 10.23 | 10.26 | 9.98 | 0.369 times |
| 26 Fri Jul 2024 | 10.25 | 10.29 | 10.42 | 10.17 | 0.484 times |
| 25 Thu Jul 2024 | 10.21 | 9.97 | 10.27 | 9.89 | 0.598 times |
Stock of Theravance Biopharma (TBPH) has showed a significant fall. This could be a good time to exit from this stock.
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 8.2, for a target of 9 or 9.68
Share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Target | 7.69 |
| Upside Target | 8.13 |
| Upside Target | 8.65 |
| Upside Target | 9.01 |
| Upside Target | 9.41 |
| Upside Target | 10.22 |
| Upside Target | 10.23 |
| Upside Target | 10.35 |
| Upside Target | 10.37 |
| Upside Target | 10.42 |
| Upside Target | 10.44 |
Intraday share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Intraday Target | 7.12 |
| Downside Intraday Target | 6.42 |
| Upside Intraday Target | 9.1 |
| Upside Intraday Target | 10.38 |
| Upside Intraday Target | 8.4 |
Weekly technical analysis of Theravance Biopharma (TBPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Wed Aug 2024 | 7.83 | 9.24 | 9.67 | 7.69 | 4.235 times |
| 02 Fri Aug 2024 | 9.64 | 10.23 | 10.35 | 9.58 | 1.024 times |
| 26 Fri Jul 2024 | 10.25 | 9.60 | 10.42 | 9.60 | 0.73 times |
| 19 Fri Jul 2024 | 9.57 | 9.41 | 10.23 | 9.41 | 0.841 times |
| 12 Fri Jul 2024 | 9.37 | 8.82 | 9.76 | 8.65 | 5.322 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Wed Aug 2024 | 7.83 | 10.16 | 10.22 | 7.69 | 0.867 times |
| 31 Wed Jul 2024 | 10.11 | 8.46 | 10.42 | 8.19 | 1.048 times |
| 28 Fri Jun 2024 | 8.48 | 8.68 | 9.01 | 8.28 | 0.833 times |
| 31 Fri May 2024 | 8.62 | 8.44 | 10.37 | 8.13 | 0.993 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Theravance Biopharma in short term and the sell signal is strong.
Theravance Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.44 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Theravance Biopharma in short term and the sell signal is strong.
Theravance Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.44 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.